Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M353Revenue $M60.1Net Margin (%)-155.4Z-Score-28.1
Enterprise Value $M297EPS $-0.7Operating Margin %-143.5F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-156.9Higher ROA y-yN
Price/Book8.110-y EBITDA Growth Rate %-45.2Quick Ratio2.1Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %-39.4Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-121.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-330.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M180ROI % (ttm)-75.7Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO LOUIS AEVP,Finance and Administration 2015-04-23Sell10,000$1.931.55 view
Plunkett MatthewEVP, Corporate Development 2015-04-06Sell16,569$1.884.26 view
BIANCO JAMES APresident and CEO 2015-03-23Sell175,199$1.950.51 view
Plunkett MatthewEVP, Corporate Development 2015-03-23Sell59,130$1.960 view
SINGER JACK WEVP, Global Medical Affairs 2015-03-20Sell67,600$1.941.03 view
BIANCO LOUIS AEVP, Finance & Administration 2015-03-20Sell63,000$1.941.03 view
Plunkett MatthewEVP, Corporate Development 2015-03-04Sell12,000$2.41-18.67 view
SINGER JACK WEVP Global Medical Affairs 2015-02-27Sell15,000$2.35-16.6 view
BIANCO LOUIS AEVP, Finance & Administration 2015-02-05Sell10,000$2.22-11.71 view
Plunkett MatthewEVP, Corporate Development 2015-02-04Sell12,000$2.22-11.71 view

Press Releases about CTIC :

    Quarterly/Annual Reports about CTIC:

    News about ctic:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    comment on CTIC Dec 16 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

    More From Our Partners
    What Makes CTI BioPharma (CTIC) a Strong Sell? - Tale of the Tape Mar 26 2015 - ZACKS

    More From Other Websites
    CTI BioPharma to Report First Quarter 2015 Financial Results on May 6, 2015 Apr 23 2015
    CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be... Apr 22 2015
    CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be... Apr 22 2015
    1:05 am CTI BioPharma and Baxter (BAX) announce Phase 3 data of... Apr 22 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 31 2015
    What Makes CTI BioPharma (CTIC) a Strong Sell? - Tale of the Tape Mar 26 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Mar 23 2015
    Biotech Stock Mailbag: Breaking the Feuerstein-Ratain Rule; Medical Conferences; Celgene Mar 20 2015
    CTI BIOPHARMA CORP Financials Mar 19 2015
    Small Biotech Firm Quietly Makes +1,000% Price Move Mar 17 2015
    3 Stocks Near 52-Week Lows to Buy Now - Analyst Blog Mar 16 2015
    CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With... Mar 16 2015
    CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With... Mar 16 2015
    3 Biotech Stocks on Traders' Radars: Technical Charts Mar 13 2015
    CTI BioPharma Discloses More Data on Myelofibrosis Drug in SEC Filing Mar 13 2015
    CTI BioPharma reports 4Q loss Mar 12 2015
    CTI BioPharma Reports Fourth Quarter And Full Year 2014 Financial Results Mar 12 2015
    CTi Biopharma Corp Earnings Call scheduled for 4:30 pm ET today Mar 12 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 12 2015
    CTI BIOPHARMA CORP Files SEC form 10-K, Annual Report Mar 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK